Zhejiang Gongdong Medical Technology Co., Ltd. Stock: price and insider trades · China
拱东医疗
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,600 shares2.2% of flowA股XSHGSSE:173000008744685820
- 8,000 shares3.6% of flowA股XSHGSSE:173000008719093060
- 33,000 shares15.7% of flowA股XSHGSSE:173000008709525200
- 11,500 shares5.4% of flowA股XSHGSSE:173000008705772300
- 13,120 shares6.2% of flowA股XSHGSSE:173000008701990940
- 18,000 shares8.6% of flowA股XSHGSSE:173000008693711740
- 17,196 shares8.2% of flowA股XSHGSSE:173000008685009900
- 30,000 shares14.3% of flowA股XSHGSSE:173000008679724960
- 35,500 shares17.0% of flowA股XSHGSSE:173000008675845980
- 39,000 shares18.6% of flowA股XSHGSSE:173000008668709980
- 100 shares100.0% of flowA股XSHGSSE:173000008108950850
11 of 11 declarations
About Zhejiang Gongdong Medical Technology Co., Ltd.
All 11 filings at Zhejiang Gongdong Medical Technology Co., Ltd. (拱东医疗), a Chinese health care company listed in Shanghai, are sales, worth EUR 768,373 in total with a median of EUR 63,217. Almost everything comes from one filer: 钟卫峰, 董事 and 高级管理人员, signs 10 filings, including the three largest, close together in March 2025: EUR 143,003 on March 14, EUR 130,658 on March 17 and EUR 120,852 on March 27. 赖俊丞, 副总经理, signs the remaining one.
The record runs from June 20, 2024 to April 1, 2025: one filing in 2024, 10 in 2025. There are therefore only 2 filers and no purchase, and no filing falls in the last twelve months. Market capitalisation is CNY 3.7 billion, with 69.3% of the capital held by insiders. The three largest sales all belong to that filer and fall within March 2025. 赖俊丞 appears once, as 副总经理. Sales are the only kind of filing in the record: no purchase, grant or option exercise appears.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
